Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AGA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07273799
What this trial is testing

Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia

Who this might be right for
Androgenic Alopecia
Sheikh Zayed Federal Postgraduate Medical Institute 200
Early research (Phase 1)Ended earlyNCT02676310
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)

Who this might be right for
AlopeciaAlopecia, AndrogeneticBaldness
Allergan 53
Not applicableLooking for participantsNCT07502976
What this trial is testing

Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia

Who this might be right for
Androgenic Alopecia
Kasr El Aini Hospital 60
Not applicableStudy completedNCT02494297
What this trial is testing

DUS on the Prescribing Indications for CPA/EE in 5 European Countries

Who this might be right for
HirsutismAndrogenetic AlopeciaSevere Anemia+2 more
Center for Epidemiology and Health Research, Germany 1,597
Not applicableStudy completedNCT06149221
What this trial is testing

Penetration-enhanced Direct DBD Non-thermal Plasma for Hair Loss

Who this might be right for
Androgenetic Alopecia
Dr. Peter C. Friedman 19
Testing effectiveness (Phase 2)Study completedNCT01451151
What this trial is testing

Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542)

Who this might be right for
Androgenetic AlopeciaMale Pattern BaldnessFemale Pattern Baldness
Aderans Research Institute 33
Large-scale testing (Phase 3)Study completedNCT00958750
What this trial is testing

Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia

Who this might be right for
Androgenetic AlopeciaFemale Pattern Hair Loss
Charite University, Berlin, Germany 113
Testing effectiveness (Phase 2)Study completedNCT01900041
What this trial is testing

Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss

Who this might be right for
Female Pattern Hair LossAndrogenetic Alopecia (AGA)Ludwig Type 1+1 more
Merz Pharmaceuticals GmbH 74
Testing effectiveness (Phase 2)Study completedNCT01451021
What this trial is testing

Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss

Who this might be right for
Androgenetic AlopeciaMale Pattern BaldnessFemale Pattern Baldness
Aderans Research Institute 21
Post-approval studies (Phase 4)UnknownNCT06110377
What this trial is testing

MALE HAIR LOSS - Treatment With Dutasteride Mesotherapy x Dutasteride MMP Technique (Injections With Tattoo Machine)

Who this might be right for
Androgenic Alopecia
Clinica Dermatologica Arbache ltda 60
Testing effectiveness (Phase 2)Study completedNCT02170662
What this trial is testing

Topical Bimatoprost Effect on Androgen Dependent Hair Follicles

Who this might be right for
Male Pattern Hair LossAndrogenetic Alopecia
Duke University 33
Not applicableLooking for participantsNCT07079657
What this trial is testing

Thulium Laser and Growth Factors for Androgenetic Alopecia

Who this might be right for
Androgenetic Alopecia (AGA)
Universitätsklinikum Hamburg-Eppendorf 30
Testing effectiveness (Phase 2)Study completedNCT02781311
What this trial is testing

A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males

Who this might be right for
Alopecia
Allergan 169
Post-approval studies (Phase 4)Study completedNCT00198601
What this trial is testing

Determination of Gentamicin Dosing in Neonatal Patients

Who this might be right for
Infection
Johns Hopkins Bloomberg School of Public Health
Large-scale testing (Phase 3)Looking for participantsNCT04594018
What this trial is testing

Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia

Who this might be right for
Androgenetic Alopecia
EMS 190
Not applicableStudy completedNCT01437163
What this trial is testing

Treatment of Androgenetic Alopecia in Males and Females

Who this might be right for
Androgenetic Alopecia
Apira Science, Inc. 88
Large-scale testing (Phase 3)Study completedNCT05914805
What this trial is testing

Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)

Who this might be right for
Alopecia, Androgenetic
Cassiopea SpA 762
Early research (Phase 1)Study completedNCT05380427
What this trial is testing

A Phase I Clinical Trial Evaluating the Safety, Tolerability, and Pharmacokinetics of CU-40101 Liniment in Single and Multiple Doses in Adult Male Androgenic Alopecia Subjects

Who this might be right for
AGA
Cutia Therapeutics（Wuxi）Co.,Ltd 80
Not applicableStudy completedNCT03506503
What this trial is testing

Condensed Nanofat Grafting for Treatment of Androgenetic Alopecia

Who this might be right for
Androgenic Alopecia
Jinan University Guangzhou 10
Testing effectiveness (Phase 2)Study completedNCT01451112
What this trial is testing

Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002899)

Who this might be right for
Androgenetic AlopeciaMale Pattern BaldnessFemale Pattern Baldness
Aderans Research Institute 30
Next Page